Related Experiment Video
Updated: Jan 14, 2026

Isolation of Human Lymphatic Endothelial Cells by Multi-parameter Fluorescence-activated Cell Sorting
Published on: May 1, 2015
Anti-angiogenesis in human lymphomas. New insights
Domenico Ribatti1, Roberto Tamma1, Giuseppe Ingravallo2
1Department of Translational Biomedicine and Neuroscience, University of Bari Medical School, Bari, Italy.
None:
Targeting tumor angiogenesis is an advancement in the treatment of hematological malignancies. This article summarizes the most recent advancements in the use of anti-angiogenic agents in the treatment of human lymphomas. Preclinical and clinical studies have evidenced that treating lymphomas with anti-angiogenic monotherapy may not be successful. Alternative therapeutic strategies may be used to overcome resistance to anti-angiogenic therapy, including the association of different anti-angiogenic molecules or their combination with other treatment regimens.

